What is the appropriate workup and management for a patient with syndrome of inappropriate antidiuretic hormone secretion (SIADH) presenting with hyponatremia?

Workup and Management of SIADH with Hyponatremia

Diagnostic Confirmation

SIADH is diagnosed by demonstrating hypotonic hyponatremia (serum sodium <134 mEq/L, plasma osmolality <275 mOsm/kg) with inappropriately concentrated urine (>500 mOsm/kg) and elevated urinary sodium (>20 mEq/L) in a clinically euvolemic patient with normal thyroid, adrenal, and renal function. 1, 2

Essential Laboratory Tests

• Serum sodium and osmolality to confirm hyponatremia and hypoosmolality 1, 3
• Urine osmolality (should be >100 mOsm/kg, typically >300-500 mOsm/kg despite low serum osmolality) 1, 2
• Urine sodium concentration (typically >20-40 mEq/L, reflecting continued sodium excretion) 1, 3
• Serum creatinine and BUN to exclude renal insufficiency 1
• Thyroid-stimulating hormone (TSH) to rule out hypothyroidism 1
• Morning cortisol or ACTH stimulation test to exclude adrenal insufficiency 1
• Serum uric acid (<4 mg/dL has 73-100% positive predictive value for SIADH) 1, 2

Volume Status Assessment

• Clinical euvolemia is mandatory for SIADH diagnosis – absence of orthostatic hypotension, dry mucous membranes, edema, ascites, or jugular venous distention 1, 3
• Physical examination alone has poor accuracy (sensitivity 41%, specificity 80%), so incorporate laboratory parameters 1
• Distinguish SIADH from cerebral salt wasting (CSW) in neurosurgical patients: SIADH presents with euvolemia and CVP 6-10 cm H₂O, while CSW shows hypovolemia with CVP <6 cm H₂O 1, 2

---

Treatment Algorithm Based on Severity

Severe Symptomatic Hyponatremia (Seizures, Coma, Altered Mental Status)

Administer 3% hypertonic saline immediately with a target correction of 6 mmol/L over 6 hours or until severe symptoms resolve, but never exceed 8 mmol/L total correction in any 24-hour period. 1, 2

• Transfer to ICU for close monitoring 1, 2
• Give 100 mL boluses of 3% NaCl IV over 10 minutes, repeating up to three times at 10-minute intervals if needed 1
• Monitor serum sodium every 2 hours during initial correction phase 1, 2
• Maximum correction limit: 8 mmol/L in 24 hours to prevent osmotic demyelination syndrome 1, 2
• For high-risk patients (cirrhosis, alcoholism, malnutrition), limit correction to 4-6 mmol/L per day 1

Mild Symptomatic or Asymptomatic SIADH (Sodium <120 mEq/L)

Fluid restriction to 1 L/day is the cornerstone of treatment for chronic SIADH. 1, 2

• Restrict fluid intake to ≤1 L/day (or <800 mL/day for refractory cases) 1, 4
• Add oral sodium chloride 100 mEq three times daily if no response to fluid restriction alone 1
• Monitor serum sodium every 24-48 hours initially, then adjust frequency based on response 1
• Target correction rate of 1.0 mEq/L/day with fluid restriction 4

Moderate Hyponatremia (Sodium 120-125 mmol/L)

• Fluid restriction to 1-1.5 L/day as first-line therapy 1, 2
• Consider albumin infusion in hospitalized patients as adjunctive therapy 2
• Continue monitoring and adjust based on response 2

---

Pharmacological Options for Refractory SIADH

Second-Line Therapies

• Demeclocycline induces nephrogenic diabetes insipidus and reduces kidney response to ADH; effective for chronic SIADH when fluid restriction fails 1, 2, 5
• Tolvaptan (vasopressin receptor antagonist): FDA-approved, starting dose 15 mg once daily, titrate to 30-60 mg as needed; produces mean correction rate of 3.0 mEq/L/day 1, 4
• Urea is considered very effective and safe in recent literature 2
• Loop diuretics (furosemide) combined with oral salt replacement for acute management 5
• Lithium (less commonly used due to side effects) 2, 5

Comparative Efficacy

• Hypertonic saline: 3.0 mEq/L/day correction rate (most rapid) 4
• Tolvaptan: 3.0 mEq/L/day correction rate 4
• Isotonic saline: 1.5 mEq/L/day correction rate 4
• Fluid restriction: 1.0 mEq/L/day correction rate (slowest but safest for chronic management) 4

---

Special Considerations and Critical Pitfalls

Identify and Treat Underlying Cause

• Discontinue offending medications immediately: SSRIs, carbamazepine, chlorpropamide, cyclophosphamide, vincristine, NSAIDs, opioids 1, 2, 6
• Evaluate for malignancy (especially small cell lung cancer), CNS disorders, pulmonary diseases 1, 2
• Treat underlying cancer in paraneoplastic SIADH; effective cancer treatment often resolves the syndrome 2

Neurosurgical Patients

• Never use fluid restriction in subarachnoid hemorrhage patients at risk for vasospasm – it worsens outcomes and increases cerebral ischemia risk 1, 2
• Consider fludrocortisone 0.1-0.2 mg daily in SAH patients to prevent vasospasm 1, 2
• Distinguish SIADH from cerebral salt wasting: CSW requires volume and sodium replacement, not fluid restriction 1, 2

Common Errors to Avoid

• Overly rapid correction (>8 mmol/L in 24 hours) causes osmotic demyelination syndrome – characterized by dysarthria, dysphagia, oculomotor dysfunction, quadriparesis appearing 2-7 days after correction 1
• Inadequate monitoring during active correction increases risk of complications 1
• Using fluid restriction in CSW instead of SIADH worsens hypovolemia and outcomes 1, 2
• Failing to obtain appropriate diagnostic tests – only <50% of patients in registry studies had proper laboratory confirmation, yet success rates were significantly higher when tests were obtained 4
• Discharging patients still hyponatremic – 75% had sodium <135 mEq/L and 43% had sodium ≤130 mEq/L at discharge in registry data 4

High-Risk Populations Requiring Slower Correction

• Advanced liver disease, chronic alcoholism, malnutrition, prior encephalopathy: limit to 4-6 mmol/L per day maximum 1, 2
• Elderly patients have increased sensitivity to hyponatremia due to reduced GFR 1
• Patients on multiple CNS medications (antidepressants, antipsychotics, benzodiazepines) have compounded risk 1

---

Monitoring Protocol

• Severe symptoms: Check serum sodium every 2 hours during initial correction 1, 2
• After symptom resolution: Check every 4-6 hours 1
• Chronic management: Monitor every 24-48 hours initially, then adjust based on stability 1
• Watch for osmotic demyelination signs 2-7 days after correction 1
• If overcorrection occurs: Administer desmopressin or D5W to relower sodium and bring total 24-hour correction back to ≤8 mmol/L 1